Clinical Trial
The cost effectiveness of auranofin: results of a randomized clinical trial
Affiliations
- PMID: 3127585
Item in Clipboard
Clinical Trial
The cost effectiveness of auranofin: results of a randomized clinical trial
J Rheumatol.
1988 Jan.
Abstract
In a 6-month randomized trial at 14 sites, the cost effectiveness of auranofin (AF) treatment for patients with rheumatoid arthritis was gauged in comparison with placebo. Measures of global health and of impacts on daily life suggest that the benefits of disease modification outweigh adverse effects after 4 and 6 months of treatment (p less than 0.01), with negligible differences between placebo and treated patients after 1 and 2 months. Additional medical costs directly associated with AF treatment amounted to $778/patient annually. Observed differences in less direct medical costs, help received, and earnings were not statistically significant.
Similar articles
-
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.J Rheumatol. 1988 Jan;15(1):28-34. J Rheumatol. 1988. PMID: 3280795 Clinical Trial.
-
Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.J Rheumatol. 1987 Feb;14(1):55-9. J Rheumatol. 1987. PMID: 3106632 Clinical Trial.
-
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.J Rheumatol. 1988 Dec;15(12):1747-54. J Rheumatol. 1988. PMID: 14552308 Clinical Trial.
-
[Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial].Zhonghua Nei Ke Za Zhi. 1993 Jul;32(7):486-8. Zhonghua Nei Ke Za Zhi. 1993. PMID: 8275829 Review. Chinese. No abstract available.
-
Measuring costs and financial benefits in randomized controlled trials.Am Heart J. 1990 Mar;119(3 Pt 2):766-70; discussion 770-1. doi: 10.1016/s0002-8703(05)80059-6. Am Heart J. 1990. PMID: 2106770 Review.
Cited by
-
Thoughts on health economics in rheumatoid arthritis.Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii35-9. doi: 10.1136/ard.2007.078964. Ann Rheum Dis. 2007. PMID: 17934092 Free PMC article. Review.
-
Measuring performance in clinical rheumatology.Ann Rheum Dis. 1990 Jan;49(1):3-5. doi: 10.1136/ard.49.1.3. Ann Rheum Dis. 1990. PMID: 2106840 Free PMC article. Review. No abstract available.
-
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.Pharmacoeconomics. 1999 Feb;15(2):141-55. doi: 10.2165/00019053-199915020-00003. Pharmacoeconomics. 1999. PMID: 10351188 Review.
-
[Performance appraisal of internal health services].Soz Praventivmed. 1992;37(4):179-87. doi: 10.1007/BF01624573. Soz Praventivmed. 1992. PMID: 1414019 French.
-
Rheumatoid arthritis and sexuality: a patient survey in France.BMC Musculoskelet Disord. 2012 Sep 10;13:170. doi: 10.1186/1471-2474-13-170. BMC Musculoskelet Disord. 2012. PMID: 22963081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical